Company Profile

Growth Journey

Mission

Providing anti-aging solutions based on innovative materials

Founded

January 12, 2016

Capital

USD 0.1 M

CEO

Cha Mi-Sun

Employees

50 Persons

2024 ~ Present

Scale-Up Stage

2025

  • Res Novae Scalp MD: kFDA approval & FDA/CE Listing
  • Applied for clinical trial IND for chitosan LTG-Syno
  • Selected for govt-funded R&D project (USD 1.73M)

2024

  • Launched Res Novae beauty business division
  • Applied for clinical trial IND for chitosan LTG-S
  • Selected for govt-funded R&D project (USD 1.55M)
2020 ~ 2023

Preparation Stage

2023

  • Launched Res Novae product brand
  • Entered into export agreement (USD 5M)
  • Obtained regulatory approval from Thailand (Husteon)

2022

  • Selected for govt-funded R&D project (USD 0.44M)
  • Relocation & expansion, factory registration
  • Entered into export agreement (USD 2M)
  • Obtained kFDA approval for Husteon Mesh/Nasal

2021

  • Selected as "Innovation Enterprise National Representative 1000"
  • Obtained kFDA approval for Husteon Mesh
  • Completed FDA listing for Husteon Nasal
  • Launched Echrever (for export)

2020

  • Obtained medical device manufacturing license
  • Acquired export approval for Husteon
  • Obtained ISO13485 certification
  • Selected for govt-funded R&D project (USD 1.7M)
~ 2019

Early Stage

2019

Govt-funded R&D project (USD 0.5M)
ISO9001, ISO14001 Certification

2018

Govt-funded R&D project (USD 0.6M)
Certified as venture enterprise

2016

Medifab incorporated